Hollings Renton, Director at ANAPTYSBIO, INC (ANAB), sold 41,850 shares at $23.82 ($986K) on 2025-07-02, disclosed to the SEC on 2025-07-03.
Scheduled sale ($986k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $23.09 | 7,250 | $167K | 17.0% |
| 2 | $23.09 | 7,250 | $167K | 17.0% |
| 3 | $23.82 | 13,675 | $326K | 33.0% |
| 4 | $23.82 | 13,675 | $326K | 33.0% |
| Total | $23.57 avg | 41,850 | $986K | 100% |
| Filing → |
| ANAB | SELL | 2024-12-03 | $250K | — | Filing → |
| ANAB | SELL | 2024-07-17 | $613K | — | Filing → |
| ANAB | SELL | 2024-06-18 | $45K | — | Filing → |